Related Experiment Video
Updated: May 20, 2026
08:28
Vapor Phase Deposition of Electroactive Poly(3,4-ethylenedioxythiophene) onto Electrospun Commodity Polymer Nanofibers
Published on: March 7, 2025
Electrospun nanofibers in drug delivery: recent developments and perspectives
Gareth R Williams1, Nicholas P Chatterton, Tahir Nazir
1School of Human Sciences, Faculty of Life Sciences, London Metropolitan University, 166-220 Holloway Road, London, N7 8DB, UK.
Therapeutic Delivery
|July 28, 2012
Summary
Electrospinning offers a promising solution for drug delivery challenges like poor solubility and degradation. This technique creates nanofibers that enhance drug targeting and stability, improving therapeutic outcomes.
Area of Science:
- Biomaterials Science
- Pharmaceutical Technology
- Nanotechnology
Background:
- Key challenges in drug delivery include poor solubility, drug degradation, and inefficient targeting.
- Existing methods often face limitations in overcoming these persistent issues.
- Developing advanced drug delivery systems is crucial for improving therapeutic efficacy.
Purpose of the Study:
- To review the challenges in drug delivery.
- To introduce electrospinning as a potential solution.
- To explore the application of electrospun nanofibers in overcoming drug delivery hurdles.
Main Methods:
- Literature review of drug delivery challenges and solutions.
- Introduction to the electrospinning technique and its parameters.
- Analysis of recent studies on electrospun nanofibers for drug delivery.
Main Results:
- Electrospinning produces nanofibers with tunable properties.
- Electrospun nanofibers demonstrate potential in enhancing drug solubility.
- Fibers show promise in protecting drugs from degradation and improving targeting.
Conclusions:
- Electrospun nanofibers represent a versatile platform for advanced drug delivery.
- This technique can effectively address critical issues like solubility, degradation, and targeting.
- Further research into electrospinning holds significant promise for future therapeutics.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...